Hacef Dosage & Drug Information

Concise Prescribing Info

Contents

Ceftazidime pentahydrate

Indications/Uses

Treatment of infection due to sensitive gm +ve & gm -ve bacteria.

Dosage/Direction for Use

Usual dose: 1 g 8-12 hrly; range from 250 mg-2 g 8-12 hrly continue for at least 2 days. Childn 1 mth-12 yr 30-50 mg/kg 8 hrly. Max: 6 g/24 hr. Infant up to 4 wk 30 mg/kg 12 hrly.

Special Precautions

History of allergy. Hypersensitivity to other cephalosporins. Renal impairment. Monitor renal & hematological status.

Adverse Reactions

Burning, discomfort & pain at inj site; diarrhea; elevated alkaline phosphate, SGOT, SGPT; nausea & vomiting; +ve Coombs' test; pseudomembranous colitis; seizures (large doses).

View ADR Monitoring Form

Drug Interactions

Aminoglycosides.

MIMS Class

Cephalosporins

ATC Classification

J01DD02 - ceftazidime ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Regulatory Classification

Presentation/Packing

Form

Hacef powd for inj 1 g

Packing/Price

(+ 5 mL diluent) 10 × 1's; (+ 5 mL diluent) 1's

Form

Hacef powd for inj 2 g

Packing/Price

(+ 2 amp 5 mL diluent) 1's

Form

Hacef powd for inj 500 mg

Packing/Price

(+ 5 mL diluent) 10 × 1's; (+ 5 mL diluent) 1's

Hacef

ceftazidime

Manufacturer:

Harbin

Distributor:

Endure Medical